UK Body Urges Action On Licensing Delays As MHRA Unveils Guidance For Established Products

Regulator Aims To Shorten Timeframes For Assessment Of Established Medicines

Clock moving fast with blur, high speed concept
Speedier approvals are needed to clear the MHRA backlog • Source: Shutterstock

More from Regulation

More from Policy & Regulation